Skip to main content

Table 4 Summary of period means of overall ACQ-5 score for mean of visit 3–5 at country/area level

From: Real-life effectiveness of budesonide/formoterol maintenance and reliever therapy in asthma patients across Asia: SMARTASIA study

Overall score

 

N

Visit 2 (baseline)

Mean of visit 3-5

Mean change

95% confidence interval

Paired t-test

 

Mean

Range

Mean

Range

 

Lower

Upper

p-value

Country or Area

China

386

1.72

0.0 - 5.0

1.14

0.0 - 4.4

−0.58

−0.67

−0.49

<.0001

 

India

159

1.87

0.0 - 5.4

1.12

0.0 - 3.3

−0.74

−0.92

−0.57

<.0001

 

Indonesia

61

1.78

0.0 - 3.8

0.61

0.0 - 2.9

−1.18

−1.40

−0.95

<.0001

 

Taiwan

100

1.11

0.0 - 4.8

0.89

0.0 - 2.9

−0.22

−0.38

−0.06

0.0089

 

Thailand

128

1.31

0.0 - 3.6

0.95

0.0 - 2.9

−0.36

−0.48

−0.23

<.0001